<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-MedLine.d115">
    <sentence id="DDI-MedLine.d115.s0" text="Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.">
        <entity id="DDI-MedLine.d115.s0.e0" charOffset="12-27"
            type="drug" text="cyclophosphamide"/>
        <entity id="DDI-MedLine.d115.s0.e1" charOffset="30-40"
            type="drug" text="doxorubicin"/>
        <entity id="DDI-MedLine.d115.s0.e2" charOffset="43-53"
            type="drug" text="vincristine"/>
        <entity id="DDI-MedLine.d115.s0.e3" charOffset="60-69"
            type="drug" text="prednisone"/>
        <entity id="DDI-MedLine.d115.s0.e4" charOffset="89-116"
            type="group" text="highly active antiretroviral"/>
        <pair id="DDI-MedLine.d115.s0.p0" e1="DDI-MedLine.d115.s0.e0"
            e2="DDI-MedLine.d115.s0.e1" ddi="false"/>
        <pair id="DDI-MedLine.d115.s0.p1" e1="DDI-MedLine.d115.s0.e0"
            e2="DDI-MedLine.d115.s0.e2" ddi="false"/>
        <pair id="DDI-MedLine.d115.s0.p2" e1="DDI-MedLine.d115.s0.e0"
            e2="DDI-MedLine.d115.s0.e3" ddi="false"/>
        <pair id="DDI-MedLine.d115.s0.p3" e1="DDI-MedLine.d115.s0.e0"
            e2="DDI-MedLine.d115.s0.e4" ddi="false"/>
        <pair id="DDI-MedLine.d115.s0.p4" e1="DDI-MedLine.d115.s0.e1"
            e2="DDI-MedLine.d115.s0.e2" ddi="false"/>
        <pair id="DDI-MedLine.d115.s0.p5" e1="DDI-MedLine.d115.s0.e1"
            e2="DDI-MedLine.d115.s0.e3" ddi="false"/>
        <pair id="DDI-MedLine.d115.s0.p6" e1="DDI-MedLine.d115.s0.e1"
            e2="DDI-MedLine.d115.s0.e4" ddi="false"/>
        <pair id="DDI-MedLine.d115.s0.p7" e1="DDI-MedLine.d115.s0.e2"
            e2="DDI-MedLine.d115.s0.e3" ddi="false"/>
        <pair id="DDI-MedLine.d115.s0.p8" e1="DDI-MedLine.d115.s0.e2"
            e2="DDI-MedLine.d115.s0.e4" ddi="false"/>
        <pair id="DDI-MedLine.d115.s0.p9" e1="DDI-MedLine.d115.s0.e3"
            e2="DDI-MedLine.d115.s0.e4" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d115.s1" text="BACKGROUND: The feasibility and efficacy of concomitant chemotherapy and highly active antiretroviral therapy (HAART) is still unknown in patients with human immunodeficiency virus (HIV)-related malignancies. ">
        <entity id="DDI-MedLine.d115.s1.e0" charOffset="73-100"
            type="group" text="highly active antiretroviral"/>
    </sentence>
    <sentence id="DDI-MedLine.d115.s2" text="To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy. ">
        <entity id="DDI-MedLine.d115.s2.e0" charOffset="244-259"
            type="drug" text="cyclophosphamide"/>
        <entity id="DDI-MedLine.d115.s2.e1" charOffset="262-272"
            type="drug" text="doxorubicin"/>
        <entity id="DDI-MedLine.d115.s2.e2" charOffset="275-285"
            type="drug" text="vincristine"/>
        <entity id="DDI-MedLine.d115.s2.e3" charOffset="292-301"
            type="drug" text="prednisone"/>
        <entity id="DDI-MedLine.d115.s2.e4" charOffset="440-455"
            type="drug" text="cyclophosphamide"/>
        <entity id="DDI-MedLine.d115.s2.e5" charOffset="458-468"
            type="drug" text="doxorubicin"/>
        <entity id="DDI-MedLine.d115.s2.e6" charOffset="471-480"
            type="drug" text="teniposide"/>
        <entity id="DDI-MedLine.d115.s2.e7" charOffset="487-496"
            type="drug" text="prednisone"/>
        <entity id="DDI-MedLine.d115.s2.e8" charOffset="503-513"
            type="drug" text="vincristine"/>
        <entity id="DDI-MedLine.d115.s2.e9" charOffset="520-528"
            type="drug" text="bleomycin"/>
        <entity id="DDI-MedLine.d115.s2.e10" charOffset="549-562"
            type="group" text="antiretroviral"/>
        <pair id="DDI-MedLine.d115.s2.p0" e1="DDI-MedLine.d115.s2.e0"
            e2="DDI-MedLine.d115.s2.e1" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p1" e1="DDI-MedLine.d115.s2.e0"
            e2="DDI-MedLine.d115.s2.e2" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p2" e1="DDI-MedLine.d115.s2.e0"
            e2="DDI-MedLine.d115.s2.e3" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p3" e1="DDI-MedLine.d115.s2.e0"
            e2="DDI-MedLine.d115.s2.e4" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p4" e1="DDI-MedLine.d115.s2.e0"
            e2="DDI-MedLine.d115.s2.e5" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p5" e1="DDI-MedLine.d115.s2.e0"
            e2="DDI-MedLine.d115.s2.e6" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p6" e1="DDI-MedLine.d115.s2.e0"
            e2="DDI-MedLine.d115.s2.e7" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p7" e1="DDI-MedLine.d115.s2.e0"
            e2="DDI-MedLine.d115.s2.e8" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p8" e1="DDI-MedLine.d115.s2.e0"
            e2="DDI-MedLine.d115.s2.e9" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p9" e1="DDI-MedLine.d115.s2.e0"
            e2="DDI-MedLine.d115.s2.e10" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p10" e1="DDI-MedLine.d115.s2.e1"
            e2="DDI-MedLine.d115.s2.e2" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p11" e1="DDI-MedLine.d115.s2.e1"
            e2="DDI-MedLine.d115.s2.e3" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p12" e1="DDI-MedLine.d115.s2.e1"
            e2="DDI-MedLine.d115.s2.e4" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p13" e1="DDI-MedLine.d115.s2.e1"
            e2="DDI-MedLine.d115.s2.e5" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p14" e1="DDI-MedLine.d115.s2.e1"
            e2="DDI-MedLine.d115.s2.e6" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p15" e1="DDI-MedLine.d115.s2.e1"
            e2="DDI-MedLine.d115.s2.e7" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p16" e1="DDI-MedLine.d115.s2.e1"
            e2="DDI-MedLine.d115.s2.e8" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p17" e1="DDI-MedLine.d115.s2.e1"
            e2="DDI-MedLine.d115.s2.e9" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p18" e1="DDI-MedLine.d115.s2.e1"
            e2="DDI-MedLine.d115.s2.e10" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p19" e1="DDI-MedLine.d115.s2.e2"
            e2="DDI-MedLine.d115.s2.e3" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p20" e1="DDI-MedLine.d115.s2.e2"
            e2="DDI-MedLine.d115.s2.e4" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p21" e1="DDI-MedLine.d115.s2.e2"
            e2="DDI-MedLine.d115.s2.e5" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p22" e1="DDI-MedLine.d115.s2.e2"
            e2="DDI-MedLine.d115.s2.e6" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p23" e1="DDI-MedLine.d115.s2.e2"
            e2="DDI-MedLine.d115.s2.e7" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p24" e1="DDI-MedLine.d115.s2.e2"
            e2="DDI-MedLine.d115.s2.e8" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p25" e1="DDI-MedLine.d115.s2.e2"
            e2="DDI-MedLine.d115.s2.e9" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p26" e1="DDI-MedLine.d115.s2.e2"
            e2="DDI-MedLine.d115.s2.e10" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p27" e1="DDI-MedLine.d115.s2.e3"
            e2="DDI-MedLine.d115.s2.e4" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p28" e1="DDI-MedLine.d115.s2.e3"
            e2="DDI-MedLine.d115.s2.e5" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p29" e1="DDI-MedLine.d115.s2.e3"
            e2="DDI-MedLine.d115.s2.e6" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p30" e1="DDI-MedLine.d115.s2.e3"
            e2="DDI-MedLine.d115.s2.e7" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p31" e1="DDI-MedLine.d115.s2.e3"
            e2="DDI-MedLine.d115.s2.e8" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p32" e1="DDI-MedLine.d115.s2.e3"
            e2="DDI-MedLine.d115.s2.e9" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p33" e1="DDI-MedLine.d115.s2.e3"
            e2="DDI-MedLine.d115.s2.e10" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p34" e1="DDI-MedLine.d115.s2.e4"
            e2="DDI-MedLine.d115.s2.e5" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p35" e1="DDI-MedLine.d115.s2.e4"
            e2="DDI-MedLine.d115.s2.e6" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p36" e1="DDI-MedLine.d115.s2.e4"
            e2="DDI-MedLine.d115.s2.e7" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p37" e1="DDI-MedLine.d115.s2.e4"
            e2="DDI-MedLine.d115.s2.e8" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p38" e1="DDI-MedLine.d115.s2.e4"
            e2="DDI-MedLine.d115.s2.e9" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p39" e1="DDI-MedLine.d115.s2.e4"
            e2="DDI-MedLine.d115.s2.e10" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p40" e1="DDI-MedLine.d115.s2.e5"
            e2="DDI-MedLine.d115.s2.e6" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p41" e1="DDI-MedLine.d115.s2.e5"
            e2="DDI-MedLine.d115.s2.e7" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p42" e1="DDI-MedLine.d115.s2.e5"
            e2="DDI-MedLine.d115.s2.e8" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p43" e1="DDI-MedLine.d115.s2.e5"
            e2="DDI-MedLine.d115.s2.e9" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p44" e1="DDI-MedLine.d115.s2.e5"
            e2="DDI-MedLine.d115.s2.e10" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p45" e1="DDI-MedLine.d115.s2.e6"
            e2="DDI-MedLine.d115.s2.e7" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p46" e1="DDI-MedLine.d115.s2.e6"
            e2="DDI-MedLine.d115.s2.e8" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p47" e1="DDI-MedLine.d115.s2.e6"
            e2="DDI-MedLine.d115.s2.e9" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p48" e1="DDI-MedLine.d115.s2.e6"
            e2="DDI-MedLine.d115.s2.e10" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p49" e1="DDI-MedLine.d115.s2.e7"
            e2="DDI-MedLine.d115.s2.e8" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p50" e1="DDI-MedLine.d115.s2.e7"
            e2="DDI-MedLine.d115.s2.e9" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p51" e1="DDI-MedLine.d115.s2.e7"
            e2="DDI-MedLine.d115.s2.e10" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p52" e1="DDI-MedLine.d115.s2.e8"
            e2="DDI-MedLine.d115.s2.e9" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p53" e1="DDI-MedLine.d115.s2.e8"
            e2="DDI-MedLine.d115.s2.e10" ddi="false"/>
        <pair id="DDI-MedLine.d115.s2.p54" e1="DDI-MedLine.d115.s2.e9"
            e2="DDI-MedLine.d115.s2.e10" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d115.s3" text="METHODS: All patients were enrolled in two sequential trials performed at the Aviano Cancer Center, Italy, from April 1988 to December 1998. "/>
    <sentence id="DDI-MedLine.d115.s4" text="HAART was included with combination therapy from January 1997. "/>
    <sentence id="DDI-MedLine.d115.s5" text="Antiretroviral regimens consisted of two reverse transcriptase inhibitors and one protease inhibitor. ">
        <entity id="DDI-MedLine.d115.s5.e0" charOffset="0-13"
            type="group" text="Antiretroviral"/>
        <entity id="DDI-MedLine.d115.s5.e1" charOffset="41-72"
            type="group" text="reverse transcriptase inhibitors"/>
        <entity id="DDI-MedLine.d115.s5.e2" charOffset="82-99"
            type="group" text="protease inhibitor"/>
        <pair id="DDI-MedLine.d115.s5.p0" e1="DDI-MedLine.d115.s5.e0"
            e2="DDI-MedLine.d115.s5.e1" ddi="false"/>
        <pair id="DDI-MedLine.d115.s5.p1" e1="DDI-MedLine.d115.s5.e0"
            e2="DDI-MedLine.d115.s5.e2" ddi="false"/>
        <pair id="DDI-MedLine.d115.s5.p2" e1="DDI-MedLine.d115.s5.e1"
            e2="DDI-MedLine.d115.s5.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d115.s6" text="RESULTS: The two treatment groups were well matched with regard to patient demographics, NHL characteristics, HIV status, and treatment, i.e., the number of cycles and chemotherapy dose. "/>
    <sentence id="DDI-MedLine.d115.s7" text="The response rates were similar between the two groups. "/>
    <sentence id="DDI-MedLine.d115.s8" text="Severe anemia (Grade 3-4 according to the World Health Organization criteria) was significantly greater in the patients who received CHOP-HAART compared with the patients who received CHOP alone (33% vs. 7%, respectively; P = 0.001). "/>
    <sentence id="DDI-MedLine.d115.s9" text="Leukopenia was similar between the two groups, but colony stimulating factor support was significantly greater in the CHOP-HAART group than in the control group (92% vs. 66%, respectively; P = 0.03). "/>
    <sentence id="DDI-MedLine.d115.s10" text="Seventeen percent of CHOP-HAART patients developed severe autonomic neurotoxicity, whereas none of the CHOP patients developed neurotoxicity (P = 0.002). "/>
    <sentence id="DDI-MedLine.d115.s11" text="At similar median follow-up, opportunistic infection (OI) rates and mortality were significantly lower in the CHOP-HAART patients than in the CHOP patients (18% vs. 52%, respectively; P = 0.05; and 38% vs. 85%, respectively; P = 0.001). "/>
    <sentence id="DDI-MedLine.d115.s12" text="The median survival for CHOP-HAART patients was not reached, whereas the medial survival of CHOP patients was 7 months (P = 0.03). "/>
    <sentence id="DDI-MedLine.d115.s13" text="CONCLUSIONS: The combination of CHOP plus HAART is feasible and may reduce the morbidity from OIs in HIV-NHL patients. "/>
    <sentence id="DDI-MedLine.d115.s14" text="However, careful attention must be directed to cross toxicity and possible pharmacokinetic interactions between antiretroviral and antineoplastic drugs. ">
        <entity id="DDI-MedLine.d115.s14.e0"
            charOffset="112-125;146-150" type="group" text="antiretroviral drugs"/>
        <entity id="DDI-MedLine.d115.s14.e1" charOffset="131-150"
            type="group" text="antineoplastic drugs"/>
        <pair id="DDI-MedLine.d115.s14.p0" e1="DDI-MedLine.d115.s14.e0"
            e2="DDI-MedLine.d115.s14.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-MedLine.d115.s15" text="The impact of the combined chemotherapy plus HAART treatment on patient survival needs urgently to be evaluated in prospective studies."/>
</document>
